Predicting plasma concentration of quetiapine in patients with depression using machine learning techniques based on real-world evidence

References

• McCarron RM, Shapiro B, Rawles J, et al. Depression. Ann Intern Med. 2021;174(5):ITC65–80. doi: 10.7326/AITC202105180
   PubMed Web of Science ®Google Scholar
• Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299–2312. doi: 10.1016/S0140-6736(18)31948-2
   PubMed Web of Science ®Google Scholar
• Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: Double trouble. Neuron. 2020;107(2):234–256. doi: 10.1016/j.neuron.2020.06.002
   PubMed Web of Science ®Google Scholar
• Thapar A, Eyre O, Patel V, et al. Depression in young people. Lancet. 2022;400(10352):617–631. doi: 10.1016/S0140-6736(22)01012-1
   PubMed Web of Science ®Google Scholar
• Shorey S, Ng ED, Wong CHJ. Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis. Br J Clin Psychol. 2022;61(2):287–305. doi: 10.1111/bjc.12333
   PubMed Web of Science ®Google Scholar
• Farnam A, MehrAra A, Dadashzadeh H, et al. Studying the effect of sertraline in reducing aggressive behavior in patients with major depression. Adv Pharm Bull. 2017;7(2):275–279. doi: 10.15171/apb.2017.033
   PubMedGoogle Scholar
• Ruberto VL, Jha MK, Murrough JW. PharmacologIcal treatments for patients with treatment-resistant depression. Pharmaceuticals (Basel). 2020;13(6):116. doi: 10.3390/ph13060116
   PubMedGoogle Scholar
• Lj L, Ma X. Chinese guidelines for the prevention and treatment of depression. Second ed. China: China Medical Electronic Audio Visual Press; 2015.
   Google Scholar
• Guo W, Yu Z, Gao Y, et al. A machine learning model to predict risperidone active moiety concentration based on initial therapeutic drug monitoring. Front Psychiatry. 2021;12:711868. doi: 10.3389/fpsyt.2021.711868
   PubMed Web of Science ®Google Scholar
• Hiemke C, Bergemann N, Clement HW, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017. Pharmacopsychiatry. 2018;51(1–02):e1. doi: 10.1055/s-0037-1600991
   PubMed Web of Science ®Google Scholar
• Goecks J, Jalili V, Heiser LM, et al. How machine learning will transform biomedicine. Cell. 2020;181(1):92–101. doi: 10.1016/j.cell.2020.03.022
   PubMed Web of Science ®Google Scholar
• Gautier T, Ziegler LB, Gerber MS, et al. Artificial intelligence and diabetes technology: A review. Metabolism. 2021;124:154872. doi: 10.1016/j.metabol.2021.154872
   PubMed Web of Science ®Google Scholar
• Rani P, Kotwal S, Manhas J, et al. Machine learning and deep learning based computational approaches in automatic microorganisms image recognition: Methodologies, challenges, and developments. Arch Comput Methods Eng. 2022;29(3):1801–1837. doi: 10.1007/s11831-021-09639-x
   PubMed Web of Science ®Google Scholar
• Yu Z, Ye X, Liu H, et al. Predicting lapatinib dose regimen using machine learning and deep learning techniques based on a real-world study. Front Oncol. 2022;12:893966. doi: 10.3389/fonc.2022.893966
   PubMed Web of Science ®Google Scholar
• Yu Z, Ji H, Xiao J, et al. Predicting adverse drug events in Chinese pediatric inpatients with the associated risk factors: A machine learning study. Front Pharmacol. 2021;12:659099. doi: 10.3389/fphar.2021.659099
   PubMed Web of Science ®Google Scholar
• Guo, W, Zhang, L, Wang, G. Expert consensus on clinical application of psychiatric therapeutic drug monitoring in China (2022 edition). Journal of Neuroscience and Mental Health. 2022;22(08):601–608.
   Google Scholar
• Arik SO, Pfister T. TabNet: Attentive interpretable tabular learning. 2019. https://doi.org/10.48550/arXiv.1908.07442
   Google Scholar
• Chen T, Guestrin C. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, San Francisco, ACM, 13–17 August 2016. 2016:785–794.
   Google Scholar
• Zhang J, Mucs D, Norinder U, et al. LightGBM: An effective and scalable algorithm for prediction of chemical toxicity-application to the Tox21 and mutagenicity data sets. J Chem Inf Model. 2019;59(10):4150–4158. doi: 10.1021/acs.jcim.9b00633
   PubMed Web of Science ®Google Scholar
• Prokhorenkova L, Gusev G, Vorobev A, et al. Catboost: Unbiased boosting with categorical features. arXiv Preprint arXiv. 2017; p. 1706.
   Google Scholar
• Breiman L. Random Forests. Mach Learn. 2001;45(1):5–32. doi: 10.1023/A:1010933404324
   Web of Science ®Google Scholar
• Ke G, Meng Q, Finley T, et al. “A highly efficient gradient boosting decision tree.” in Proceedings of the Advances in Neural Information Processing Systems. Long Beach, CA, USA: Curran Associates, Inc. 2017:p. 3146–3154.
   Google Scholar
• Aha DW, Kibler D, Albert MK. Instance-based learning algorithms. Mach Learn. 1991;6(1):37–66. doi: 10.1007/BF00153759
   Web of Science ®Google Scholar
• Spina E, de Leon J. Metabolic drug interactions with newer antipsychotics: a comparative review. Basic Clin Pharmacol Toxicol. 2007;100(1):4–22. doi: 10.1111/j.1742-7843.2007.00017.x
   PubMed Web of Science ®Google Scholar
• Cutler AJ, Montgomery SA, Feifel D, et al. Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study. J Clin Psychiatry. 2009;70(4):526–539. doi: 10.4088/JCP.08m04592
   PubMed Web of Science ®Google Scholar
• El-Khalili N, Joyce M, Atkinson S, et al. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study. Int J Neuropsychopharmacol. 2010;13(7):917–932. doi: 10.1017/S1461145710000015
   PubMed Web of Science ®Google Scholar
• Bauer M, Pretorius HW, Constant EL, et al. Extended-release quetiapine as adjunct to an antidepressant in patients with major depressive disorder: results of a randomized, placebo-controlled, double-blind study. J Clin Psychiatry. 2009;70(4):540–549. doi: 10.4088/JCP.08m04629
   PubMed Web of Science ®Google Scholar
• Højlund M, Lund LC, Andersen K, et al. Association of low-dose quetiapine and diabetes. JAMA Netw Open. 2021;4(5):e213209. doi: 10.1001/jamanetworkopen.2021.3209
   PubMed Web of Science ®Google Scholar
• Stäuble CK, Lampert ML, Mikoteit T, et al. Severe adverse drug reactions to quetiapine in two patients carrying CYP2D6*4 variants: A case report. Int J Mol Sci. 2021;22(12):6480. doi: 10.3390/ijms22126480
   PubMed Web of Science ®Google Scholar
• Swissmedic Arzneimittelinformation. [(accessed on 23 Mar 2021)]; Available online: https://www.swissmedicinfo.ch/.
   Google Scholar
• Food and Drug Administration. Seroquel XR (quetiapine fumarate) AstraZeneca pharmaceuticals LP. Wilmington DE: USA; 2018.
   Google Scholar
• Matsuzaki T, Kato Y, Mizoguchi H, et al. A machine learning model that emulates experts’ decision making in vancomycin initial dose planning. J Pharmacol Sci. 2022;148(4):358–363. doi: 10.1016/j.jphs.2022.02.005
   PubMed Web of Science ®Google Scholar
• Ma P, Liu R, Gu W, et al. Construction and interpretation of prediction model of teicoplanin trough concentration via machine learning. Front Med. 2022;9:808969. doi: 10.3389/fmed.2022.808969
   Web of Science ®Google Scholar
• Zheng P, Yu Z, Mo L, et al. An individualized medication model of sodium valproate for patients with bipolar disorder based on machine learning and deep learning techniques. Front Pharmacol. 2022;13:890221. doi: 10.3389/fphar.2022.890221
   PubMed Web of Science ®Google Scholar
• Simon N, Torrents R, Azorin JM. Comorbidities and the right dose: antipsychotics. Expert Opin Drug Metab Toxicol. 2022;18(7–8):507–518. doi: 10.1080/17425255.2022.2113378
   PubMed Web of Science ®Google Scholar
• DeVane CL, Nemeroff CB. Clinical pharmacokinetics of quetiapine: an atypical antipsychotic. Clin Pharmacokinet. 2001;40(7):509–522. doi: 10.2165/00003088-200140070-00003
   PubMed Web of Science ®Google Scholar
• Albantakis L, Egberts K, Burger R, et al. Relationship between daily dose, serum concentration, and clinical response to quetiapine in children and adolescents with psychotic and mood disorders. Pharmacopsychiatry. 2017;50(6):248–255. doi: 10.1055/s-0043-109695
   PubMed Web of Science ®Google Scholar
• Le Daré B, Ferron PJ, Allard PM, et al. New insights into quetiapine metabolism using molecular networking. Sci Rep. 2020;10(1):19921. doi: 10.1038/s41598-020-77106-x
   PubMed Web of Science ®Google Scholar
• Atasoy N, Erdogan A, Yalug I, et al. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(6):1255–1260. doi: 10.1016/j.pnpbp.2007.05.005
   PubMed Web of Science ®Google Scholar
• Okui D, Sasaki T, Fushimi M, et al. The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor. Clin Exp Nephrol. 2020;24(Suppl 1):92–102. doi: 10.1007/s10157-019-01817-3
   PubMed Web of Science ®Google Scholar
• Aichhorn W, Marksteiner J, Walch T, et al. Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations. Int Clin Psychopharmacol. 2006;21(2):81–85. doi: 10.1097/01.yic.0000188213.46667.f1
   PubMed Web of Science ®Google Scholar
• Castberg I, Westin AA, Skogvoll E, et al. Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine. Acta Psychiatr Scand. 2017;136(5):455–464. doi: 10.1111/acps.12794
   PubMed Web of Science ®Google Scholar
• Cabaleiro T, López-Rodríguez R, Román M, et al. Pharmacogenetics of quetiapine in healthy volunteers: association with pharmacokinetics, pharmacodynamics, and adverse effects. Int Clin Psychopharmacol. 2015;30(2):82–88. doi: 10.1097/YIC.0000000000000047
   PubMed Web of Science ®Google Scholar
• Xu Q, Wu X, Li M, et al. Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population. Pharmacogenomics J. 2016;16(4):357–365. doi: 10.1038/tpj.2015.61
   PubMed Web of Science ®Google Scholar
• Zheng L, Tang S, Tang R, et al. Dose adjustment of quetiapine and aripiprazole for pregnant women using physiologically based pharmacokinetic modeling and simulation. Clin Pharmacokinet. 2021;60(5):623–635. doi: 10.1007/s40262-020-00962-3
   PubMed Web of Science ®Google Scholar